BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27986137)

  • 1. Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel.
    Abdelmaksoud A; Filoni A; Giudice G; Vestita M
    J Am Acad Dermatol; 2017 Jan; 76(1):153-155. PubMed ID: 27986137
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical timolol for Kaposi sarcoma: An innovation.
    Abdelmaksoud A; Filoni A; Giudice G; Vestita M
    Australas J Dermatol; 2018 Nov; 59(4):340-341. PubMed ID: 29624656
    [No Abstract]   [Full Text] [Related]  

  • 3. Classic Kaposi's sarcoma treated with topical 0.5% timolol gel.
    Alcántara-Reifs CM; Salido-Vallejo R; Garnacho-Saucedo GM; Vélez García-Nieto A
    Dermatol Ther; 2016 Sep; 29(5):309-311. PubMed ID: 27329079
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of cutaneous iatrogenic Kaposi sarcoma with topical timolol.
    Chap S; Vu M; Robinson AJ; Braue A; Varigos GA; Scardamaglia L
    Australas J Dermatol; 2017 Aug; 58(3):242-243. PubMed ID: 28853153
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical timolol for treatment of penile Kaposi sarcoma in HIV-negative patient.
    Sainz-Gaspar L; Suárez-Peñaranda JM; Pousa-Martínez M; Vázquez-Veiga H; Fernández-Redondo V
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28677301
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid complete regression of an early infantile hemangioma with topical timolol gel.
    Semkova K; Kazandjieva J
    Int J Dermatol; 2014 Feb; 53(2):241-2. PubMed ID: 24261914
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of classic Kaposi sarcoma with topical timolol: report of two cases.
    Meseguer-Yebra C; Cardeñoso-Álvarez ME; Bordel-Gómez MT; Fraile-Alonso MC; Pérez-Losada ME; Sánchez-Estella J
    Br J Dermatol; 2015 Sep; 173(3):860-2. PubMed ID: 25704866
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergic contact dermatitis caused by timolol eyedrop application for classic Kaposi sarcoma.
    Pérez-Tato B; Polimón I; Marinero S; Lozano-Masdemont B; de la Cruz E; Galván C
    Australas J Dermatol; 2020 Nov; 61(4):e414-e416. PubMed ID: 32542767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical timolol gel for infantile hemangiomas: a pilot study.
    Pope E; Chakkittakandiyil A
    Arch Dermatol; 2010 May; 146(5):564-5. PubMed ID: 20479314
    [No Abstract]   [Full Text] [Related]  

  • 10. Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.
    Rosen T
    Int J Dermatol; 2006 Jul; 45(7):854-6. PubMed ID: 16863526
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical ophthalmic solution in infantile hemangioma.
    Jha AK; Mallik SK; Raihan M
    J Postgrad Med; 2012; 58(2):163-5. PubMed ID: 22718070
    [No Abstract]   [Full Text] [Related]  

  • 12. Iatrogenic Kaposi's Sarcoma Successfully Treated with Topical Timolol.
    Espadafor-López B; Cuenca-Barrales C; Salvador-Rodriguez L; Ruiz-Villaverde R
    Actas Dermosifiliogr (Engl Ed); 2020 Mar; 111(2):176-178. PubMed ID: 31208673
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma.
    Giorgio CMR; Licata G; Briatico G; Babino G; Fulgione E; Gambardella A; Alfano R; Argenziano G
    Int J Dermatol; 2021 May; 60(5):631-633. PubMed ID: 33410502
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical timolol for small hemangiomas of infancy.
    Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
    Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous HIV-associated Kaposi sarcoma: a potential setting for management by clinical observation.
    Beatrous SV; Grisoli SB; Riahi RR; Cohen PR
    Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tufted angioma successfully treated with topical timolol gel-forming solution.
    Behera B; Remya R; Chandrashekar L; Thappa DM; Gochhait D
    Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):581-584. PubMed ID: 34219431
    [No Abstract]   [Full Text] [Related]  

  • 17. First report of topical timolol treatment in primarily ulcerated perineal haemangioma.
    Cante V; Pham-Ledard A; Imbert E; Ezzedine K; Léauté-Labrèze C
    Arch Dis Child Fetal Neonatal Ed; 2012 Mar; 97(2):F155-6. PubMed ID: 22190187
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
    Sorrell J; Chamlin SL
    Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical timolol for small infantile hemangioma: a new therapy option.
    Weissenstein A; Straeter A; Villalon G; Bittmann S
    Turk J Pediatr; 2012; 54(2):156-8. PubMed ID: 22734302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
    Danarti R; Ariwibowo L; Radiono S; Budiyanto A
    Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.